Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.7K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.7K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

52
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
52
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

236
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
236
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

56
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
56
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

66
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
66
Vaccinations01:51

Vaccinations

46.4K
Overview
46.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccinating the Vulnerable Heart: RSV Prevention in Atrial Fibrillation.

European journal of preventive cardiology·2026
Same author

Deleterious impact of obstructive sleep apnea on autonomic nervous system control during rapid-eye-movement sleep in adult type 1 diabetes.

Physiological reports·2026
Same author

A simplified geometric CMR method for reproducible quantification of left ventricular thrombus volume : Left Ventricular thrombus: a standardized measurement method.

The international journal of cardiovascular imaging·2026
Same author

Social deprivation among people living with HIV in the French-swiss Cross-border area: the need for targeted interventions.

AIDS care·2026
Same author

Impact of the MonCœur smartphone application on self-care and quality of life in heart failure: The APPLIMONCOEUR randomized trial.

Archives of cardiovascular diseases·2026
Same author

Correction: Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.

PloS one·2026

Related Experiment Video

Updated: Oct 17, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.3K

Vaccination for Respiratory Infections in Patients with Heart Failure.

Nicolas Girerd1, Nicolas Chapet2, Camille Roubille3

  • 1Centre d'Investigations Cliniques-INSERM CHRU de Nancy, Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu, Université de Lorraine, 54500 Vandœuvre-lès-Nancy, France.

Journal of Clinical Medicine
|October 13, 2021
PubMed
Summary

Respiratory infections worsen heart failure (HF). Vaccinations against influenza, pneumococcus, and COVID-19 may protect HF patients from cardiovascular events, but coverage is suboptimal, necessitating improved health policies.

Keywords:
COVID-19 vaccineheart failureinfluenza vaccinepneumococcal vaccinerespiratory infectionsreview articlevaccination coverage

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.0K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.2K

Related Experiment Videos

Last Updated: Oct 17, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.3K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.0K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.2K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Bronchopulmonary infections are significant triggers of cardiac decompensation and hospitalizations in heart failure (HF) patients.
  • Influenza and Streptococcus pneumoniae infections can lead to adverse cardiac effects through inflammatory and thrombotic pathways.
  • Current vaccination guidelines recommend influenza and pneumococcal vaccines for cardiovascular disease patients and HF patients, respectively.

Purpose of the Study:

  • To review the pathophysiology linking inflammation, infection, and HF.
  • To summarize current knowledge on the protective effects of influenza, pneumococcal, and COVID-19 vaccines in HF patients.
  • To propose strategies for improving vaccination coverage in this vulnerable population.

Main Methods:

  • Literature review summarizing existing research on respiratory infections and HF.
  • Analysis of the pathophysiological mechanisms connecting infection, inflammation, and cardiac function.
  • Discussion of current vaccination recommendations and their implementation gaps.

Main Results:

  • Influenza and pneumococcal infections are linked to cardiovascular events in HF patients.
  • Large clinical trials are needed to confirm the cardiovascular benefits of influenza and pneumococcal vaccines in HF.
  • The protective effect of COVID-19 vaccination in HF patients requires further investigation, though recommendations exist.

Conclusions:

  • Vaccination against respiratory infections is crucial for managing heart failure patients.
  • Suboptimal vaccination coverage highlights the need for enhanced national health policies and multi-provider involvement.
  • Improving vaccination rates can mitigate cardiovascular risks associated with infections in HF.